Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to bupivacaine for iliopsoas plane block in hip surgery
PACTR202611491655925Phase 4Not yet recruiting
- Sponsor
- Mansoura University Faculty of Medicine
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and bupivacaine in N/A (2 arms), sponsored by Mansoura University Faculty of Medicine. Primary endpoint: Time to first rescue opioid analgesia. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
N/A
Beyond the preview
Go deeper on PACTR202611491655925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202611491655925.